Literature DB >> 22292746

Modulation of MMPs by cell surface integrin receptor α5β1.

Sekhar Pal1, Kirat Kumar Ganguly, Shuvojit Moulik, Amitava Chatterjee.   

Abstract

MMPs are a family of Zn dependent endopeptidases, which can mediate degradation of ECM components during various physiological and pathological processes including cancer. Some ECM components, through interaction with integrin receptor and modulation of downstream signaling, are capable of regulating expression and activity of several MMPs. α₅β₁ integrin is the universally accepted receptor for the ECM component fibronectin (FN). The present review deals with the downstream signaling involved in the α₅β₁ integrin mediated modulation of expression and activity of MMPs and their effector responses in different cellular system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22292746     DOI: 10.2174/187152012802650183

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  4 in total

1.  Extracellular matrix protein laminin induces matrix metalloproteinase-9 in human breast cancer cell line mcf-7.

Authors:  Sekhar Pal; Shuvojit Moulik; Anindita Dutta; Amitava Chatterjee
Journal:  Cancer Microenviron       Date:  2014-05-26

2.  Changes in osteogenic gene expression in hypertrophic chondrocytes induced by SIN-1.

Authors:  Ying He; Wen Yao; Meng Zhang; Ying Zhang; Dan Zhang; Zhuocheng Jiang; Tianyou Ma; Jian Sun; Mingming Shao; Jinghong Chen
Journal:  Exp Ther Med       Date:  2018-06-07       Impact factor: 2.447

3.  Design and Evaluation of a Polypeptide that Mimics the Integrin Binding Site for EDA Fibronectin to Block Profibrotic Cell Activity.

Authors:  Lin Zhang; Hongyu Yan; Yifan Tai; Yueming Xue; Yongzhen Wei; Kai Wang; Qiang Zhao; Shufang Wang; Deling Kong; Adam C Midgley
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

4.  Role of Integrin β1 in the progression and chemo-resistance of esophageal squamous cell carcinoma.

Authors:  Ying-Hua Xie; Li-Qiang Ran; Zhi-Yong Wu; Chun Sun; Xiu-E Xu; Hai-Ying Zou; Wang-Kai Fang; Jian-Jun Xie
Journal:  J Cancer       Date:  2022-03-28       Impact factor: 4.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.